HAS1 and adrenal cortex carcinoma: In the TCGA project, high expression of HAS1 was associated with poor overall survival (OS) in adrenocortical carcinoma (ACC), KIRP, and poor OS and DFS in GBM, KIRC (Fig. 2a).